Results 111 to 120 of about 4,026 (283)

Lessons Learned From a Delayed‐Start Trial of Modafinil for Freezing of Gait in Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Freezing of gait (FOG) in people with Parkinson's disease (PwPD) is debilitating and has limited treatments. Modafinil modulates beta/gamma band activity in the pedunculopontine nucleus (PPN), like PPN deep brain stimulation. We therefore tested the hypothesis that Modafinil would improve FOG in PwPD.
Tuhin Virmani, Lakshmi Pillai, Reid D. Landes, Aliyah Glover, Shannon Doerhoff, Jennifer Kleiner, Mitesh Lotia, Rohit Dhall, Edgar Garcia‐Rill   +8 more
wiley   +1 more source

Analysis of the Risks Associated with the Functions of a Pharmacy Cleaner in Pharmaceutical Compounding

Регуляторные исследования и экспертиза лекарственных средств
INTRODUCTION. Pharmacy compounding involves certain risks that are directly related to the process of extemporaneous preparation and the actions of its participants.
E. A. Voronina, M. G. Eliseeva, A. E. Potapova, N. V. Vorobyova, S. N. Egorova   +4 more
doaj   +1 more source

Trends in Pharmacy Compounding for Women’s Health in North Carolina: Focus on Vulvodynia

, 2014
Susan H Corbett, Gary S. Cuddeback, Jasmine Lewis, Swasan As-Sanie, Denniz Zolnoun   +4 more
openalex   +1 more source

Remote Monitoring in Myasthenia Gravis: Exploring Symptom Variability

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Myasthenia gravis (MG) is a rare, autoimmune disorder characterized by fluctuating muscle weakness and potential life‐threatening crises. While continuous specialized care is essential, access barriers often delay timely interventions. To address this, we developed MyaLink, a telemedical platform for MG patients.
Maike Stein, Maximilian Mönch, Meret Herdick, Frauke Stascheit, Sarah Hoffmann, Hannah Preßler, Philipp Mergenthaler, Carla Dusemund, Paolo Doksani, Haoqi Sun, Pushpa Narayanaswami, Andreas Meisel, Lea Gerischer, Sophie Lehnerer   +13 more
wiley   +1 more source

Characterization of Clinical Phenotype to Glial Fibrillary Acidic Protein Concentrations in Alexander Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To determine the concentration of glial fibrillary acidic protein (GFAP) in cerebrospinal fluid (CSF) and plasma in Alexander disease (AxD) and whether GFAP levels are predictive of disease phenotypes. Methods CSF and plasma were collected (longitudinally when available) from AxD participants and non‐AxD controls.
Amy T. Waldman, Asako Takanohashi, Joshua Y. Joung, Geraldine W. Liu, Kaley Arnold, Amy Pizzino, Walter Faig, Sarah Woidill, Sona Narula, Adeline L. Vanderver   +9 more
wiley   +1 more source

Clinically Relevant Outcome Measures in Women With Adrenoleukodystrophy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Adrenoleukodystrophy is a rare inherited peroxisomal disease caused by pathogenic variants in the ABCD1 gene located on the X chromosome. Although the most severe central nervous system and adrenal complications typically affect only men with adrenoleukodystrophy, the majority of women develop myeloneuropathy symptoms in adulthood.
Chenwei Yan, Elizabeth I. Pierpont, Amena S. Fine, Reena V. Kartha   +3 more
wiley   +1 more source

Sterile compounding in hospital pharmacies [PDF]

American Journal of Health-System Pharmacy, 2003
openaire   +2 more sources

Kholodnyak S. V. Hydrolytic cleavage of the pyrimidine ring in 2-aryl-[1,2,4]triazole[1,5-c]quinazolines: physicо-chemical properties and the hypoglycemic activity of the compounds synthesized / S. V. Kholodnyak, K. P. Schabelnyk, G. О. Zhernova, T. Yu .Sergeieva, V. V. Ivchuk, O. Yu. Voskoboynik, S. І. Kоvalenko, S. D. Trzhetsinskii, S. I. Okovytyy, S. V. Shishkina // News of Pharmacy. – 2015. – Vol. 83, Iss. 3. – P. 9-17.

, 2021
Івчук В.В.
openalex   +1 more source

Remote Assessment of Ataxia Severity in SCA3 Across Multiple Centers and Time Points

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Spinocerebellar ataxia type 3 (SCA3) is a genetically defined ataxia. The Scale for Assessment and Rating of Ataxia (SARA) is a clinician‐reported outcome that measures ataxia severity at a single time point. In its standard application, SARA fails to capture short‐term fluctuations, limiting its sensitivity in trials.
Marcus Grobe‐Einsler, Vivian Maas, Arian Taheri Amin, Jennifer Faber, Tamara Schaprian, Katharina Hill, Matthis Synofzik, Lisa H. Graf, Heike Jacobi, Manuela Lima, Ana F. Ferreira, Bart P. van de Warrenburg, Ilse H. J. Willemse, Dagmar Timmann, Andreas Thieme, Paola Giunti, Hector Garcia‐Moreno, Magda M. Santana, Jeannette Hübener‐Schmid, Elin H. Davies, Thomas Klockgether   +20 more
wiley   +1 more source

Pharmacy Compounding Regulationin the United Kingdom

Pharmacy & Pharmacology
 Рharmaceutical practice of advanced regulatory healthcare systems places high demands on the quality and safety of medicines, especially on compounding drugs by pharmacies. The United Kingdom is one of the countries with a developed system of legal regulation of drug treatment, which is based on the principles of effective management and is aimed not ...
D. D. Mamedov, D. S. Yurochkin, S. N. Egorova, Z. M. Golant, I. A. Narkevich   +4 more
openaire   +1 more source